Literature DB >> 28599687

Diagnostic Accuracy of Multislice CT Scan in the Detection of Occult Cervical Lymph Node Metastasis in Head and Neck Cancers.

Rubia Salman1, Munawar Hussain1, Syed Omair Adil1.   

Abstract

OBJECTIVE: To determine the diagnostic accuracy of CECTin detecting occult cervical lymph node metastasis in primary head and neck squamous cell carcinoma (SCC) patients with clinically negative cervical nodes, keeping histopathology as gold standard. STUDY
DESIGN: Cross-sectional analytical study. PLACE AND DURATION OF STUDY: Department of Radiology, Dow International Medical College, DUHS, Karachi from October 2015 till April 2016.
METHODOLOGY: Two hundred patients of head and neck squamous cell carcinoma patients with clinically negative cervical nodes were enrolled at Department of Radiology, Dow International Medical College, DUHS, Karachi from October 2015 till April 2016. Multidetector computed tomography (MDCT) was done and lesions were assessed for presence or absence of tumor to metastasis into cervical lymph nodes. Histopathology was used as gold standard.
RESULTS: The mean age was 44.89 ±9.82 years as majority of the patents were males (58.0%). CECTfindings showed 48.5% positive cases, while histopathology findings showed that there were 48.39% positive cases with sensitivity, specificity, NPV, PPV and overall diagnostic accuracy of 100%, 93%, 93%, 100% and 96.21%.
CONCLUSION: MDCTis a very effective modality in early diagnosis of cancerous involvement of SCC and its invasion into cervical lymph node metastasis promising early detection and treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28599687     DOI: 2611

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck.

Authors:  Andreas Knopf; Sven Jacob; Henning Bier; Elias Q Scherer
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-24       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.